AI/ML Innovations Inc. (AIMLF)
OTCMKTS · Delayed Price · Currency is USD
0.0251
-0.0005 (-1.95%)
At close: Feb 10, 2026
AI/ML Innovations Revenue
AI/ML Innovations had revenue of 41.69K CAD in the quarter ending October 31, 2025, with 1.66% growth. This brings the company's revenue in the last twelve months to 168.26K, down -49.78% year-over-year. In the fiscal year ending April 30, 2025, AI/ML Innovations had annual revenue of 167.31K, down -72.12%.
Revenue (ttm)
168.26K CAD
Revenue Growth
-49.78%
P/S Ratio
54.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.57M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 167.31K | -432.83K | -72.12% |
| Apr 30, 2024 | 600.14K | 112.63K | 23.10% |
| Apr 30, 2023 | 487.50K | 422.10K | 645.32% |
| Apr 30, 2022 | 65.41K | - | - |
| Apr 30, 2021 | - | - | - |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |
| CompuMed | 1.69M |
| Dogecoin Cash | 721.56K |
AI/ML Innovations News
- 13 days ago - AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board - Accesswire
- 21 days ago - AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets - Accesswire
- 4 weeks ago - AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis - Accesswire
- 4 weeks ago - AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale - Accesswire
- 6 weeks ago - AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer - Accesswire
- 2 months ago - Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy - Accesswire
- 2 months ago - AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem - Accesswire
- 2 months ago - AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing - Accesswire